The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis

OBJECTIVE: To characterize the incidence, type, and risk factors of severe infections (SI) in patients with autoimmune kidney diseases treated with rituximab (RTX). METHODS: We conducted a multicenter retrospective cohort study of adult patients with immune-related kidney diseases treated with at le...

Descripción completa

Detalles Bibliográficos
Autores principales: Odler, Balazs, Windpessl, Martin, Krall, Marcell, Steiner, Maria, Riedl, Regina, Hebesberger, Carina, Ursli, Martin, Zitt, Emanuel, Lhotta, Karl, Antlanger, Marlies, Cejka, Daniel, Gauckler, Philipp, Wiesholzer, Martin, Saemann, Marcus, Rosenkranz, Alexander R., Eller, Kathrin, Kronbichler, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586204/
https://www.ncbi.nlm.nih.gov/pubmed/34777374
http://dx.doi.org/10.3389/fimmu.2021.760708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586204/
https://www.ncbi.nlm.nih.gov/pubmed/34777374
http://dx.doi.org/10.3389/fimmu.2021.760708

Ejemplares similares